Trials / Completed
CompletedNCT02516709
Linear Source Registry for Prostate Cancer
CivaString Registry for Prostate Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- CivaTech Oncology · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Ongoing follow up for subjects implanted with the Linear Source String for prostate cancer.
Detailed description
This registry is being conducted to provide long term analysis on the use of the linear Civastring source for prostate cancer. Prospective data collection will record and demonstrate biochemical response rates. Long term side effects and adverse events will be monitored.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Linear LDR Source | The Linear LDR source is a permanent interstitial brachytherapy implant containing palladium-103 sources for the treatment of prostate cancer. |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
- First posted
- 2015-08-06
- Last updated
- 2023-09-08
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02516709. Inclusion in this directory is not an endorsement.